171 related articles for article (PubMed ID: 34319976)
1. Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning.
Cromwell EA; Osborne JCP; Unnasch TR; Basáñez MG; Gass KM; Barbre KA; Hill E; Johnson KB; Donkers KM; Shirude S; Schmidt CA; Adekanmbi V; Adetokunboh OO; Afarideh M; Ahmadpour E; Ahmed MB; Akalu TY; Al-Aly Z; Alanezi FM; Alanzi TM; Alipour V; Andrei CL; Ansari F; Ansha MG; Anvari D; Appiah SCY; Arabloo J; Arnold BF; Ausloos M; Ayanore MA; Baig AA; Banach M; Barac A; Bärnighausen TW; Bayati M; Bhattacharyya K; Bhutta ZA; Bibi S; Bijani A; Bohlouli S; Bohluli M; Brady OJ; Bragazzi NL; Butt ZA; Carvalho F; Chatterjee S; Chattu VK; Chattu SK; Cormier NM; Dahlawi SMA; Damiani G; Daoud F; Darwesh AM; Daryani A; Deribe K; Dharmaratne SD; Diaz D; Do HT; El Sayed Zaki M; El Tantawi M; Elemineh DA; Faraj A; Fasihi Harandi M; Fatahi Y; Feigin VL; Fernandes E; Foigt NA; Foroutan M; Franklin RC; Gubari MIM; Guido D; Guo Y; Haj-Mirzaian A; Hamagharib Abdullah K; Hamidi S; Herteliu C; Hidru HD; Higazi TB; Hossain N; Hosseinzadeh M; Househ M; Ilesanmi OS; Ilic MD; Ilic IM; Iqbal U; Irvani SSN; Jha RP; Joukar F; Jozwiak JJ; Kabir Z; Kalankesh LR; Kalhor R; Karami Matin B; Karimi SE; Kasaeian A; Kavetskyy T; Kayode GA; Kazemi Karyani A; Kelbore AG; Keramati M; Khalilov R; Khan EA; Khan MNN; Khatab K; Khater MM; Kianipour N; Kibret KT; Kim YJ; Kosen S; Krohn KJ; Kusuma D; La Vecchia C; Lansingh VC; Lee PH; LeGrand KE; Li S; Longbottom J; Magdy Abd El Razek H; Magdy Abd El Razek M; Maleki A; Mamun AA; Manafi A; Manafi N; Mansournia MA; Martins-Melo FR; Mazidi M; McAlinden C; Meharie BG; Mendoza W; Mengesha EW; Mengistu DT; Mereta ST; Mestrovic T; Miller TR; Miri M; Moghadaszadeh M; Mohammadian-Hafshejani A; Mohammadpourhodki R; Mohammed S; Mohammed S; Moradi M; Moradzadeh R; Moraga P; Mosser JF; Naderi M; Nagarajan AJ; Naik G; Negoi I; Nguyen CT; Nguyen HLT; Nguyen TH; Nikbakhsh R; Oancea B; Olagunju TO; Olagunju AT; Omar Bali A; Onwujekwe OE; Pana A; Pourjafar H; Rahim F; Rahman MHU; Rathi P; Rawaf S; Rawaf DL; Rawassizadeh R; Resnikoff S; Reta MA; Rezapour A; Rubagotti E; Rubino S; Sadeghi E; Saghafipour A; Sajadi SM; Samy AM; Sarmiento-Suárez R; Sawhney M; Schipp MF; Shaheen AA; Shaikh MA; Shamsizadeh M; Sharafi K; Sheikh A; Shetty BSK; Shin JI; Shivakumar KM; Simonetti B; Singh JA; Skiadaresi E; Soheili A; Soltani S; Spurlock EE; Sufiyan MB; Tabuchi T; Tapak L; Thompson RL; Thomson AJ; Traini E; Tran BX; Ullah I; Ullah S; Uneke CJ; Unnikrishnan B; Uthman OA; Vinkeles Melchers NVS; Violante FS; Wolde HF; Wonde TE; Yamada T; Yaya S; Yazdi-Feyzabadi V; Yip P; Yonemoto N; Yousof HSA; Yu C; Yu Y; Yusefzadeh H; Zaki L; Zaman SB; Zamanian M; Zhang ZJ; Zhang Y; Ziapour A; Hay SI; Pigott DM
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0008824. PubMed ID: 34319976
[TBL] [Abstract][Full Text] [Related]
2. How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control.
Verver S; Walker M; Kim YE; Fobi G; Tekle AH; Zouré HGM; Wanji S; Boakye DA; Kuesel AC; de Vlas SJ; Boussinesq M; Basáñez MG; Stolk WA
Clin Infect Dis; 2018 Jun; 66(suppl_4):S267-S274. PubMed ID: 29860291
[TBL] [Abstract][Full Text] [Related]
3. Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis.
Mutono N; Basáñez MG; James A; Stolk WA; Makori A; Kimani TN; Hollingsworth TD; Vasconcelos A; Dixon MA; de Vlas SJ; Thumbi SM
Lancet Glob Health; 2024 May; 12(5):e771-e782. PubMed ID: 38484745
[TBL] [Abstract][Full Text] [Related]
4. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
[TBL] [Abstract][Full Text] [Related]
5. Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes.
Dadzie Y; Amazigo UV; Boatin BA; Sékétéli A
Infect Dis Poverty; 2018 Jul; 7(1):63. PubMed ID: 29966535
[TBL] [Abstract][Full Text] [Related]
6. Hypo-endemic onchocerciasis hotspots: defining areas of high risk through micro-mapping and environmental delineation.
Kelly-Hope LA; Unnasch TR; Stanton MC; Molyneux DH
Infect Dis Poverty; 2015; 4():36. PubMed ID: 26279835
[TBL] [Abstract][Full Text] [Related]
7. Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective.
Cupp E; Sauerbrey M; Cama V; Eberhard M; Lammie PJ; Unnasch TR
Infect Dis Poverty; 2019 Jul; 8(1):50. PubMed ID: 31303176
[TBL] [Abstract][Full Text] [Related]
8. The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected.
Zouré HG; Noma M; Tekle AH; Amazigo UV; Diggle PJ; Giorgi E; Remme JH
Parasit Vectors; 2014 Jul; 7():326. PubMed ID: 25053392
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and control of onchocerciasis: the threshold biting rate of savannah onchocerciasis in Africa.
Duerr HP; Eichner M
Int J Parasitol; 2010 May; 40(6):641-50. PubMed ID: 19941867
[TBL] [Abstract][Full Text] [Related]
10. Research for new drugs for elimination of onchocerciasis in Africa.
Kuesel AC
Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):272-286. PubMed ID: 27693536
[TBL] [Abstract][Full Text] [Related]
11. Moxidectin: an oral treatment for human onchocerciasis.
Milton P; Hamley JID; Walker M; Basáñez MG
Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1067-1081. PubMed ID: 32715787
[TBL] [Abstract][Full Text] [Related]
12. Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal.
Traore MO; Sarr MD; Badji A; Bissan Y; Diawara L; Doumbia K; Goita SF; Konate L; Mounkoro K; Seck AF; Toe L; Toure S; Remme JH
PLoS Negl Trop Dis; 2012; 6(9):e1825. PubMed ID: 23029586
[TBL] [Abstract][Full Text] [Related]
13. Scaling-Down Mass Ivermectin Treatment for Onchocerciasis Elimination: Modeling the Impact of the Geographical Unit for Decision Making.
Stolk WA; Blok DJ; Hamley JID; Cantey PT; de Vlas SJ; Walker M; Basáñez MG
Clin Infect Dis; 2021 Jun; 72(Suppl 3):S165-S171. PubMed ID: 33909070
[TBL] [Abstract][Full Text] [Related]
14. Assessing Hypoendemic Onchocerciasis in
Rakers LJ; Emukah E; Kahansim B; Nwoke BEB; Miri ES; Griswold E; Davies E; Ityonzughul C; Anyaike C; Agbi P; Richards FO
Am J Trop Med Hyg; 2020 Dec; 103(6):2328-2335. PubMed ID: 32959756
[TBL] [Abstract][Full Text] [Related]
15. Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis.
Stolk WA; Walker M; Coffeng LE; Basáñez MG; de Vlas SJ
Parasit Vectors; 2015 Oct; 8():552. PubMed ID: 26489937
[TBL] [Abstract][Full Text] [Related]
16. Reaching the london declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa.
Turner HC; Walker M; Churcher TS; Osei-Atweneboana MY; Biritwum NK; Hopkins A; Prichard RK; Basáñez MG
Clin Infect Dis; 2014 Oct; 59(7):923-32. PubMed ID: 24944228
[TBL] [Abstract][Full Text] [Related]
17. From 'control to elimination': a strategic change to win the end game.
Hopkins AD
Int Health; 2015 Sep; 7(5):304-5. PubMed ID: 26311755
[TBL] [Abstract][Full Text] [Related]
18. Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa.
Gebrezgabiher G; Mekonnen Z; Yewhalaw D; Hailu A
Infect Dis Poverty; 2019 Jul; 8(1):60. PubMed ID: 31269966
[TBL] [Abstract][Full Text] [Related]
19. The positive influence the Onchocerciasis Elimination Program for the Americas has had on Africa programs.
Richards FO; Nwoke BEB; Zarroug I; Tukahebwa E; Negussu N; Higazi TB; Oguttu D; Tadesse Z; Miri E; Aziz N; Habomugisha P; Katabarwa M
Infect Dis Poverty; 2019 Jul; 8(1):52. PubMed ID: 31303175
[TBL] [Abstract][Full Text] [Related]
20. Can ivermectin mass treatments eliminate onchocerciasis in Africa?
Winnen M; Plaisier AP; Alley ES; Nagelkerke NJ; van Oortmarssen G; Boatin BA; Habbema JD
Bull World Health Organ; 2002; 80(5):384-91. PubMed ID: 12077614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
